The Carlyle Group Inc. 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 6:00 pm Purchase | 2024-02-08 | 13D | Jasper Therapeutics, Inc. JSPR | Carlyle Group Inc. CG | 1,066,189 7.100% | 190,000 (+21.68%) | Filing |
| 2023-01-31 4:15 pm Purchase | 2023-01-27 | 13D | Jasper Therapeutics, Inc. JSPR | Carlyle Group Inc. CG | 876,189 8.000% | 313,333 (+55.67%) | Filing |
| 2022-08-11 4:47 pm Purchase | 2022-08-01 | 13D | Jasper Therapeutics, Inc. JSPR | Carlyle Group Inc. CG | 562,856 15.400% | 562,856 (New Position) | Filing |